“A Vancouver-based biotech firm at the forefront of antibody discovery technology has just received a big financial boost from the Canadian government in its fight against COVIDcampaign-pages/bispecifics/-19. Earlier today, Canadian Prime Minister Justin Trudeau announced that AbCellera is among several companies that will share $192 million under the federal government’s new Strategic Innovation Fund’s COVIDcampaign-pages/bispecifics/-19 stream.”
Read full coverage on CBC News.